Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jianru Xiao"'
Autor:
Jialin Li, Haifeng Wei, Jianru Xiao, Jian Zhao, Xinghai Yang, Tianrui Chen, Bo Li, Pingting Zhou, Zhipeng Wu
Publikováno v:
Oncotarget
// Jialin Li 1, * , Bo Li 1, * , Pingting Zhou 2, * , Jian Zhao 1 , Zhipeng Wu 1 , Xinghai Yang 1 , Haifeng Wei 1 , Tianrui Chen 1 and Jianru Xiao 1 1 Department of Bone Tumor Surgery, Changzheng Hospital, Second Military Medical University, Shanghai
Autor:
Zhipeng Wu, Hao Cao, Bo Li, Xinghai Yang, Jianru Xiao, Qi Jia, Haifeng Wei, Ming Qian, Tianrui Chen, Tianyi Ma
Publikováno v:
Oncotarget
// Bo Li 1, * , Ming Qian 1, * , Hao Cao 2, * , Qi Jia 1, * , Zhipeng Wu 1 , Xinghai Yang 1 , Tianyi Ma 3 , Haifeng Wei 1 , Tianrui Chen 1 and Jianru Xiao 1 1 Department of Bone Tumor Surgery, Changzheng Hospital, Second Military Medical University,
Publikováno v:
Oncotarget
Few studies have reported progression-free survival (PFS) and overall survival (OS) of Metastatic spinal cord compression (MSCC) patients with primary hepatocellular carcinoma (HCC) following surgery and adjuvant therapies. Enrolled in this study wer
Autor:
Xinghai Yang, Jianru Xiao, Tielong Liu, Zhi’an Liu, Dianwen Song, Zhipeng Wu, Jing Wang, Wangjun Yan, Zhenxi Li, Wang Zhou, Huabin Yin, Ting Wang, Quan Huang, Haifeng Wei
Publikováno v:
Oncotarget
// Ting Wang 1,* , Huabin Yin 1,* , Jing Wang 1,2,* , Zhenxi Li 1 , Haifeng Wei 1 , Zhi’an Liu 2 , Zhipeng Wu 1 , Wangjun Yan 1 , Tielong Liu 1 , Dianwen Song 1 , Xinghai Yang 1 , Quan Huang 1 , Wang Zhou 1 and Jianru Xiao 1 1 Department of Bone Tu
Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR
Autor:
Xinghai Yang, Jinsong Li, Huayun Deng, Song Wu, Yuanzhang Fang, Leqin Xu, Shijie Chen, Zhenxi Li, Xiaopan Cai, Amanda Vaughn, Jianru Xiao, Meichun Hu, Wei Wan
Publikováno v:
Oncotarget
The epidermal growth factor receptor (EGFR) is a therapeutic target (oncotarget) in NSCLC. Using in vitro EGFR kinase activity system, we identified a novel small molecule, WB-308, as an inhibitor of EGFR. WB-308 decreased NSCLC cell proliferation an